These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 15494355

  • 1. Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.
    Segev Y, Eshet R, Rivkis I, Hayat C, Kachko L, Phillip M, Landau D.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3021-8. PubMed ID: 15494355
    [Abstract] [Full Text] [Related]

  • 2. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
    Landau D, Segev Y, Afargan M, Silbergeld A, Katchko L, Podshyvalov A, Phillip M.
    Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
    [Abstract] [Full Text] [Related]

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.
    Exp Clin Endocrinol Diabetes; 2007 Oct 20; 115(9):571-6. PubMed ID: 17943690
    [Abstract] [Full Text] [Related]

  • 5. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H.
    Diabetes Metab Res Rev; 2002 Oct 20; 18(3):224-37. PubMed ID: 12112941
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.
    Buléon M, Allard J, Jaafar A, Praddaude F, Dickson Z, Ranera MT, Pecher C, Girolami JP, Tack I.
    Am J Physiol Renal Physiol; 2008 May 20; 294(5):F1249-56. PubMed ID: 18367657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS.
    Nephrol Dial Transplant; 2006 Feb 20; 21(2):324-9. PubMed ID: 16249198
    [Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 20; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 13. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
    Segev Y, Eshet R, Yakir O, Haim N, Phillip M, Landau D.
    Diabetologia; 2007 Jun 20; 50(6):1327-34. PubMed ID: 17443310
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb 20; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 16. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.
    Diabetes; 2007 Feb 20; 56(2):346-54. PubMed ID: 17259378
    [Abstract] [Full Text] [Related]

  • 17. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y.
    Nephrol Dial Transplant; 2006 Mar 20; 21(3):605-15. PubMed ID: 16282336
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006 Mar 20; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.